Treating type 2 diabetes mellitus costs the UK National Health Service (NHS) £2 billion annually,doi:10.1007/BF03275380NoneSpringer International PublishingPharmacoeconomics & Outcomes News
According to NHS (2014), „A recent study has estimated that 35.3% of adults in the UK now have pre-diabetes (also known as borderline diabetes).” A country with one of the highest prevalences of diabetes is also America: „One in four Americans has either pre-diabetes or the full...
Diabetes, type 2 - CausesNHS Choices
An inexpensive weight management programme delivered in the NHS has helped patients with type 2 diabetes achieve long term weight loss and improved glycaemic control, leading to a reduction in their diabetes medicine. The study, published in Diabetes Obesity and Metabolism ,1 examined records from ...
This observational study aimed to assess trends in type 2 diabetes mellitus (T2DM) disease burden in European Union countries for the years 1990–2019. Sex specific T2DM age-standardised prevalence (ASPRs), mortality (ASMRs) and disability-adjusted life-year rates (DALYs) per 100,000 population...
NHS 2型糖尿病的管理 The management of type 2 diabetes 热度: To decrease type 2 Diabetes (T2D) among Pima Indian :降低2型糖尿病(2型糖尿病)之间的皮马印第安人 热度: 2型糖尿病 热度: AlternativeTherapiesforType2Diabetes LucyDey,MD,AnojaS.Attele,DDS,Chun-SuYuan,MD,PhD ...
Shaw1, Fiona E. Matthews2, Carol Brayne3, Julie E. Simpson1† and Stephen B. Wharton1*† on behalf of the Cognitive Function and Ageing Study Abstract Type 2 diabetes mellitus (T2D), characterised by peripheral insulin resistance, is a risk factor for ...
South Asians are at high risk of developing type 2 diabetes (T2D). We carried out a genome-wide association meta-analysis with South Asian T2D cases (n = 16,677) and controls (n = 33,856), followed by combined analyses with Europeans (neff = 231,420). We identify 21 ...
Type 2 diabetes is one of the fastest-growing health emergencies of the twenty-first century, in part due to its association with cardiovascular and renal
Being overweight or obese does not lead to improved survival among patients with type 2 diabetes. The large-scale study led by Harvard School of Public Health (HSPH) researchers refutes previous studies that have suggested that, for people with diabetes,